Skip to main content

Find Clinical Trials

Home
Conditions
Refractory Transformed Indolent Non-Hodgkin Lymphoma

Clinical trial condition

Refractory Transformed Indolent Non-Hodgkin Lymphoma

Explore clinical trials studying Refractory Transformed Indolent Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Refractory Transformed Indolent Non-Hodgkin Lymphoma trial results

Completed

Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma

NCT03583424

Conditions: Hematopoietic Cell Transplantation Recipient, Hemic and Lymphatic Diseases, Immune System Diseases, +22 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details